Augmented Three-mode MIA-QSAR Modeling for a Series of Anti-HIV-1 Compounds
暂无分享,去创建一个
[1] R. Bro. PARAFAC. Tutorial and applications , 1997 .
[2] M. P. Freitas. MIA-QSAR modelling of anti-HIV-1 activities of some 2-amino-6-arylsulfonylbenzonitriles and their thio and sulfinyl congeners. , 2006, Organic & biomolecular chemistry.
[3] K. Roy,et al. Classical QSAR Modeling of HIV‐1 Reverse Transcriptase Inhibitor 2‐Amino‐6‐arylsulfonylbenzonitriles and Congeners , 2004 .
[4] R. Bro,et al. A new efficient method for determining the number of components in PARAFAC models , 2003 .
[5] Age K. Smilde,et al. A multiway 3D QSAR analysis of a series of (S)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-6-methoxybenzamides , 1998, J. Comput. Aided Mol. Des..
[6] Max Dobler,et al. 5D-QSAR: the key for simulating induced fit? , 2002, Journal of medicinal chemistry.
[7] G. Klebe,et al. Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity. , 1994, Journal of medicinal chemistry.
[8] C. Hansch,et al. p-σ-π Analysis. A Method for the Correlation of Biological Activity and Chemical Structure , 1964 .
[9] M. P. Freitas. Multivariate QSAR: From Classical Descriptors to New Perspectives , 2007 .
[10] R. Cramer,et al. Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. , 1988, Journal of the American Chemical Society.
[11] A. Vedani,et al. Combining protein modeling and 6D-QSAR. Simulating the binding of structurally diverse ligands to the estrogen receptor. , 2005, Journal of medicinal chemistry.
[12] A. Hopfinger,et al. Construction of 3D-QSAR Models Using the 4D-QSAR Analysis Formalism , 1997 .
[13] Steven D. Brown,et al. MIA-QSAR: a simple 2D image-based approach for quantitative structure–activity relationship analysis , 2005 .
[14] F. Tian,et al. A novel atom-pair hologram (APH) and its application in peptide QSARs , 2007 .